ESA-SRB 2013*
Chairs: Roderick Clifton-Bligh & Paul Baldock
Effects of Odanacatib on BMD and overall safety in the treatment of Osteoporosis in postmenopausal women previously treated with Alendronate (#52)
1:00 PM
Patients with atypical femoral fractures have higher body mass index and femoral neck bone mineral density compared to patients with typical femoral fractures. (#53)
1:15 PM
Osteoporosis in patients with developmental disability: a clinic experience (#54)
1:30 PM
The vitamin D receptor regulates inflammatory and regenerative responses to skeletal muscle injury (#55)
1:45 PM
Muscle function decrements in men undergoing androgen deprivation therapy (ADT). (#56)
2:00 PM
Activins are potent negative regulators of muscle mass (#57)
2:15 PM